Related Experiment Video

Updated: Jun 26, 2026

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
06:24

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

Dynamic alteration of gene expression induced by anticancer-agent exposure in gastric cancer cell lines

Tsunehiro Takahashi1, Yoshiro Saikawa, Rieko Nakamura

  • 1Department of Surgery, School of Medicine, Keio University, Tokyo 160-8582, Japan.

Oncology Reports
|January 17, 2009
PubMed

Insights

Investigating gene expression in gastric cancer cell lines reveals how chemotherapy resistance develops. Understanding these gene expression patterns may lead to better cancer treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Advanced gastric cancer has a poor prognosis due to limited chemotherapy effectiveness.
  • Chemotherapy efficacy varies, influenced by gene expression and leading to drug resistance.
  • Gene expression profiling offers insights into gastric cancer development and drug response.

Purpose of the Study:

  • To investigate gene expression patterns in gastric cancer cell lines.
  • To understand alterations in gene expression following chemotherapy exposure.
  • To compare gene expression in cisplatin-resistant versus sensitive cell lines.

Main Methods:

  • Utilized TaqMan low-density array for gene expression analysis.
  • Examined the expression of 96 genes in four gastric cancer cell lines.
  • Assessed gene expression changes after exposure to cisplatin and 5-fluorouracil.

Main Results:

  • Gastric cancer cell lines showed distinct gene expression changes upon exposure to cisplatin and 5-fluorouracil.
  • Cisplatin-resistant cells exhibited different gene expression profiles compared to parental cells at multiple time points post-treatment.
  • Observed varied gene expression patterns correlating with chemotherapy response and resistance.

Conclusions:

  • Gene expression plays a critical role in gastric cancer chemotherapy response and resistance.
  • Understanding these complex gene expression alterations is key to improving treatment outcomes.
  • Findings may inform the development of novel therapeutic strategies for gastric cancer.

More Related Videos

Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells09:24

Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells

Published on: May 9, 2020

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...